Testing efficacy of the point-of-care guided hemostatic management in cyanotic congenital cardiac surgery patients.
Not Applicable
Completed
- Conditions
- Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere
- Registration Number
- CTRI/2018/07/015122
- Lead Sponsor
- Department Of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 170
Inclusion Criteria
170 patients of either gender, belonging to ASA grade I â??
III undergoing elective cardiac surgery on CPB for cyanotic
congenital heart disease will be included in this study.
Exclusion Criteria
1. Patients on preoperative anticoagulants
2. Patients with known coagulopathy other than
inherent coagulopathy associated with cyanotic heart
disease.
3. Patients undergoing redo surgery
4. Patients undergoing cardiac surgery without
involving CPB will not be included in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method